| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 9.1% | $4,736,000 | 1,600,000 | Richard Abbe | 15 Jul 2025 | |||
| CVI Investments, Inc. | 5.7% | +16% | $2,960,000 | +$1,906,577 | 1,000,000 | +181% | CVI Investments, Inc. | 15 Jul 2025 |
| ARMISTICE CAPITAL, LLC | 8.3% | $678,720 | 336,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| 3i, LP | 4.9% | -50% | $872,128 | -$821,582 | 190,006 | -49% | 3i, LP | 31 Mar 2025 |
As of 30 Sep 2025, 1 institutional investors reported holding 66 shares of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX). This represents 0% of the company’s total 4,043,321 outstanding shares.